Larvol Delta - The-Canadian-Intellectual-Property-Ofce-intends-to-grant-RhoVac39s-patent-application-for-RV001-onilcamotide-cancer-vaccine

onilcamotide (RV001) - RhoVac

https://www.prnewswire.com/news-releases/the-canadian-intellectual-property-office-intends-to-grant-rhovacs-patent-application-for-rv001-onilcamotide-cancer-vaccine-301466451.html

Jan 24, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next